Differential tumor microenvironment in human ovarian cystic tumors

Tumori

Volumn 90, Issue 5, 2004, Pages 491-497

  Tavares Murta, Beatriz Martins ^a   De Queiróz Cunha, Fernando ^b   Miranda, Rodrigo ^a   Adad, Sheila Jorge ^a   Candido Murta, Eddie Fernando ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokine; Nitric oxide; Ovarian tumor; Tumor marker; Tumor associated mononuclear cells

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; PROGESTERONE; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BENIGN TUMOR; CELL INFILTRATION; CYST FLUID; CYTOKINE RELEASE; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MONONUCLEAR CELL; NEUTROPHIL; OVARY TUMOR; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE;

EID: 9344260796     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000509     Document Type: Article

References (28)

1. Gaetje R, Popp L: Is differentiation of benign and malignant cystic adnexial masses possible by evaluation of cystic fluids? Acta Obstet Gynecol Scand, 73: 502-507, 1994.
2. Van der Zee AG, de Cuyper EM, Limburg PC, de Bruijn HW, Hollema H, Bijzet J, Krans M, de Vries EG: Higher levels of interleukin-6 in fluids from patients with malignant versus benign ovarian tumors. Cancer, 75: 1004-1009, 1995.
3. Matthes ACS, Andrade JM, Bighetti S: Selection of criteria for the treatment of ovarian cysts on the bases of ultrasound and cytology. Gynecol Obstet Invest, 42: 244-248, 1996.
4. Higgins RV, Matkins JF, Marroum MC: Comparison of fine-needle aspiration cytologic findings of ovarian cysts with ovarian histologic findings. Am J Obstet Gynecol, 180: 550-553, 1999.
5. Negus RPM, Stamp GWH, Hadley J, Balkwill FR: Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol, 150: 1723-1734, 1997.
6. Merogi AJ, Marrogi AJ, Ramesh R, Robinson WR, Fermin CD, Freeman SM: Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol, 28: 321-331, 1997.
7. Schondorf T, Engel H, Lindemann C, Kolhagen H, Von Rucker AA, Mailman P: Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours. Cancer Immunol Immunother, 44: 88-96, 1997.
8. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumor-associated macrophages. Immunol Today, 13: 265-270, 1992.
9. Mantovani G, Macciò A, Pisano M, Versace R, Lai P, Esu S, Massa E, Ghiani M, Dessì D, Melis GB, Del Giacco GS: Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines. Int J Cancer, 71: 724-731, 1997.
10. Goedegebuure PS, Douville CC, Doherty JM, Linehan DC, Lee KY, Ganguly EK, Eberlein TJ: Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer. Cell Immunol, 175: 150-156, 1997.
11. Knowles RG, Moncada S: Nitric oxide synthase in mammals. Biochem J, 298: 249-258, 1994.
12. Bussolino F, Albini A, Camussi G, Presta M, Viglietto G, Ziche M, Persico G: Role of soluble mediators in angiogenesis. Eur J Cancer, 32A: 2401-2012, 1996.
13. Thomsen LL, Sargent JM, Williamson CJ, Elgie AW: Nitric oxide synthase activity in fresh cells from ovarian tumor tissue: relationship of enzyme activity with clinical parameters of patients with ovarian cancer. Biochem Pharmacol, 56: 1365-1370, 1998.
14. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer, 72: 41-44, 1995.
15. Schmidt HHHW, Wilke, P, Evers B, Bohme E: Enzymatic formation of nitrogen oxides from L-arginine in bovine brain cytosol. Biochem Biophys Res Commun, 165: 284-291, 1989.
16. Green LC, De Luzuriaga KL, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR: Nitrate biosynthesis in man. Proc Natl Acad Sci, 78: 7764-7768, 1981.
17. Moran O, Menczer J, Ben-Baruch G, Lipitz S, Goor E: Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors. Obstet Gynecol, 82: 444-446, 1993.
18. Mulvany NJ: Aspiration cytology of ovarian cysts and cystic neoplasms. A study of 235 aspirates. Acta Cytol, 40: 911-920, 1996.
19. Cherchi PL, Capobianco G, Ambrosini G, Fadda GM, Piga MD, Ruiu G, Fattorini F, Dessole S: Intracystic evaluation of tumor markers in benign and malignant ovarian pathology. Eur J Gynaecol Oncol, 23: 163-165, 2002.
20. Vartiainen J, Lehtovirta P, Finne P, Stenman UH, Alfthan H: Preoperative serum concentration of hCG-beta as a prognostic factor in ovarian cancer. Int J Cancer, 95: 313-316, 2001.
21. Bernasconi S, Matteucci C, Sironi M, Conni M, Colotta F, Mosca M, Colombo N, Bonazzi C, Landoni F, Corbetta G, Mantovani A, Allavena P: Effects of granulocute-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int J Cancer, 60: 300-307, 1995.
22. Melani C, Pupa SM, Stoppacciaro A, Ménard S, Colnaghi MI, Parmiani G, Colombo MP: An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int J Cancer, 62: 572-578, 1995.
23. Negus RPM, Stamp GWH, Relf MG, Burke F, Malik STA, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR: The detection and localization of monocyte chemoattractant protein 1 (MCP-1) in human ovarian cancer. J Clin Invest, 95: 2391-2396, 1995.
24. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL: Expression of mRNA for cytokines in tumour-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer, 51: 573-580, 1992.
25. Rieder J, Jahnke R, Schloesser M, Seibel M, Czechowski M, Marth C, Hoffmann G: Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines. Gynecol Oncol, 82: 172-176, 2001.
26. Ambs S, Hussain SP, Harris CC: Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J, 11: 443-448, 1997.
27. Xie K, Dong Z, Fidler IJ: Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J Leukoc Biol, 59: 797-803, 1996.
28. Rojas A, Delgado R, Glaría L, Palacios M: Monocyte chemotactic protein-1 inhibits the induction of nitric oxide synthase in J774 cells. Biochem Biophys Res Commun, 196: 274-279, 1993.